Table 2.
WEST UGANDA | EAST UGANDA | KENYA | ||||
---|---|---|---|---|---|---|
VL Metric | Region Total (n=1,827) |
On ART (n=675) |
Region Total (n=1,147) |
On ART (n=458) |
Region Total (n=5,854) |
On ART (n=3,069) |
< 500 (copies/mL) | 881 (48.2%) |
568 (84.2%) |
516 (45.0%) |
345 (75.3%) |
3,093 (52.8%) |
2,514 (81.9%) |
500–1,000 | 38 (2.1%) |
6 (0.9%) |
28 (2.4%) |
10 (2.2%) |
113 (1.9%) |
43 (1.4%) |
1,000–10,000 | 284 (15.5%) |
37 (5.5%) |
133 (11.6%) |
36 (7.9%) |
722 (12.3%) |
168 (5.5%) |
10,001–100,000 | 426 (23.3%) |
42 (6.2%) |
290 (25.3%) |
49 (10.7%) |
1,198 (20.5%) |
215 (7.0%) |
> 100,000 | 198 (10.8%) |
22 (3.3%) |
180 (15.7%) |
18 (3.9%) |
728 (12.4%) |
129 (4.2%) |
Median VL, IQR | 874 (<500—24,983) |
<500 (<500—<500) |
2,124 (<500—45,404) |
<500 (<500—<500) |
<500 (<40—24,268) |
<500 (<40—<500) |
Mean log10(VL) 95% CI |
3.47 (3.41–3.52) |
2.79 (2.73–2.86) |
3.66 (3.59–3.73) |
3.00 (2.92–3.08) |
3.20 (3.17–3.24) |
2.50 (2.46–2.54) |
NOTE. VL, viral load; ART, antiretroviral therapy; IQR, interquartile range; CI, confidence interval